Home › NDC Lookup › RxCUI directory › RxCUI 1728351

1 ML butorphanol tartrate 2 MG/ML Injection — RxCUI 1728351

RxNorm drug concept · Semantic clinical drug
RxCUI 1728351 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1728351
Official name1 ML butorphanol tartrate 2 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asbutorphanol tartrate 2 MG per 1 ML Injection; butorphanol tartrate 2 MG in 1 ML Injection
FDA products mapped4
Package NDCs mapped5
Reported Medicaid activity (SDUD)940 prescriptions · 9 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Butorphanol Nasal Spray: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It's for pain that's severe enough to need an opioid when other options, like non-opioid pain relievers, haven't worked or can't be used. It isn't meant for long-term use unless yo...
  • You spray it into one or both nostrils as your prescriber directs, usually as needed with a few hours between doses. Use the lowest amount that controls your pain. Don't stop sudde...
  • Sleepiness and dizziness are the most common, and nausea, headache, constipation, dry mouth and nasal congestion can happen too. Don't drive until you know how it affects you. Call...
  • Avoid alcohol. Mixing it with sedatives like benzodiazepines, sleep aids, muscle relaxants, gabapentin or other opioids can dangerously slow your breathing. Also tell me about anti...
📖 Read our full Butorphanol Nasal Spray guide →

🕸️ Concept Web — How 1 ML butorphanol tartrate 2 MG/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 1 ML butorphanol tartrate 2 MG/ML Injection RxCUI 1728351

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Butorphanol 1841
    • Butorphanol tartrate 203170
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Butorphanol Injection 1728350
    • Butorphanol tartrate Injection 2648089
    • Butorphanol Injectable Product 1151379
    • Butorphanol tartrate Injectable Product 2660384
    • Injection 1649574
    • Injectable Product 1151126
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Butorphanol tartrate 2 MG/ML 886621

Showing up to 8 concepts per family — 9 of 9 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Butorphanol tartrate 2 MG/ML SCDC · 886621
  • Butorphanol Injection SCDF · 1728350
  • Butorphanol tartrate Injection SCDFP · 2648089
  • Butorphanol Injectable Product SCDG · 1151379
  • Butorphanol tartrate Injectable Product SCDGP · 2660384

📦 FDA Products & Package NDCs

4 products · 5 package NDCs
5 package NDCs map to RxCUI 1728351 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00143-9864-10 1 mL in 1 VIAL, SINGLE-DOSE (0143-9864-10) Butorphanol Tartrate Hikma Pharmaceuticals USA Inc. 2009-05-01
00143-9867-10 1 mL in 1 VIAL, SINGLE-DOSE (0143-9867-10) Butorphanol Tartrate Hikma Pharmaceuticals USA Inc. 2009-05-01
00409-1623-01 10 VIAL, SINGLE-DOSE in 1 CARTON (0409-1623-01) / 1 mL in 1... Butorphanol Tartrate Hospira, Inc. 2005-09-23
00409-1626-01 10 VIAL, SINGLE-DOSE in 1 CARTON (0409-1626-01) / 1 mL in 1... Butorphanol Tartrate Hospira, Inc. 2006-03-17
00409-1626-02 10 VIAL, SINGLE-DOSE in 1 CARTON (0409-1626-02) / 2 mL in 1... Butorphanol Tartrate Hospira, Inc. 2005-12-20
Observed labelers: Hospira, Inc. (3) · Hikma Pharmaceuticals USA Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J0595 Butorphanol tartrate 1 mg 3 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.